| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
| | IP | CI | | Loperamid lingual Spirig HC | 20 | 3.48 | 6.45 | 10 % | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid lingual Spirig HC | 60 | 7.93 | 25.10 | 10 % | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Loperam-X lingual | 20 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | axapharm ag | D | FB | | G |  |
| | IP | CI | | Loperamid Streuli 2 mg | 20 Capsule(s) | 3.48 | 6.45 | 10 % | | Loperamidi Hydrochloridum 2 mg | Streuli Pharma AG | ● D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid Streuli 2 mg | 60 Capsule(s) | 8.59 | 25.75 | 10 % | | Loperamidi Hydrochloridum 2 mg | Streuli Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Spirig HC 2 mg | 20 Tablet(s) | 3.48 | 6.45 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Spirig HC 2 mg | 60 Tablet(s) | 7.93 | 25.10 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Spirig HealthCare AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid-Mepha 2 ‐ I | 20 Tablet(s) | 3.48 | 6.45 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | D / SL / SG | FB | | G |  |
| | IP | CI | | Loperamid-Mepha 2 ‐ I | 60 Tablet(s) | 7.88 | 25.00 | 10 % | | Coated tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Sandoz | 20 Capsule(s) | 3.48 | 6.45 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | ● D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Sandoz | 60 Capsule(s) | 8.59 | 25.75 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | ● B / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Zentiva 2 mg | 20 | 3.48 | 6.45 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Helvepharm AG | D / SL / SG | FB | | G |  |
| | IP | CI | CM | Loperamid Zentiva 2 mg | 60 | 9.58 | 26.75 | 10 % | | Capsules: Loperamidi Hydrochloridum 2 mg | Helvepharm AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Imodium lingual - T | 20 Tablet(s) | 8.05 | 15.50 | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Loperamid-Mepha lingual 2 mg | 20 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | Mepha Pharma AG | D | FB | | G |  |
| | IP | CI | CM | Amavita Loperamid 2 mg | 20 Capsule(s) | PR | PR | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Amavita Health Care AG | D | FB | | G |  |
| | IP | CI | CM | SUN STORE Loperamid 2 mg | 20 | PR | PR | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sun Store Health Care AG | D | FB | | G |  |
| | IP | CI | | Lopimed | 20 Capsule(s) | 5.23 | 9.65 | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | C | FB | | G |  |
| | IP | CI | | Lopimed | 60 Capsule(s) | 12.15 | 26.20 | k.A. | | Capsules: Loperamidi Hydrochloridum 2 mg | Sandoz Pharmaceuticals AG | B | FB | | G |  |
|
| | IP | CI | | Imodium duo | 8 Tablet(s) | PR | PR | k.A. | | Tablets: 2 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium duo | 12 | PR | PR | k.A. | | Tablets: 2 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
|
| | IP | CI | | Ebvallo | | PR | PR | k.A. | | | Pierre Fabre Pharma SA | A | FB | | G |  |
| | IP | CI | | Imodium ‐ I - T | 20 Capsule(s) | 3.87 | 6.85 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / SL / SO | FB | | G |  |
| | IP | CI | | Imodium - T | 60 Capsule(s) | 9.40 | 26.60 | 20 % | | Capsules: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | B / SL / SO | FB | | G |  |
L | | IP | CI | | Microlax | 4 x 5 ml | 4.15 | 7.65 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL | FB | | G |  |
L | | IP | CI | | Microlax | 12 x 5 ml | 12.45 | 23.00 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | IP | CI | | Microlax | 50 x 5 ml | 51.88 | 95.80 | 10 % | | Enema: 3 Active Agents | JNTL Consumer Health II (Switzerland) GmbH | D / SL / LPPV | FB | | G |  |
L | | IP | | | Vegzelma 100 mg/4 ml | | 257.57 | 296.55 | 10 % | | Concentrate for infusion: Bevacizumabum 100mg / 4ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | | | Vegzelma 400 mg/16 ml | | 962.84 | 1063.55 | 10 % | | Concentrate for infusion: Bevacizumabum 400mg / 16ml | iQone Healthcare Switzerland SA | A / SL | FB | | G |  |
L | | IP | | PP | Herceptin subkutan 600mg/5ml | | 1484.04 | 1630.40 | 10 % | | Lösung zur subkutanen Injektion: Trastuzumabum 600mg / 5ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
L | | IP | | | Ogivri 150 mg | | 456.84 | 513.25 | 10 % | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Trastuzumabum 150 mg | Medius AG | A / SL | FB | | G |  |
| | IP | CI | | Bilaxten 6 mg / ml | 5 ml | PR | PR | k.A. | | Eye drops: Bilastinum 6 mg/ml | A. Menarini GmbH | B | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 10 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Imodium lingual akut | 12 | PR | PR | k.A. | | Melting tablets: Loperamidi Hydrochloridum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | IP | CI | | Nicorette Microtab Original-Aroma | 100 Tablet(s) | PR | PR | k.A. | | Sublingual tablets: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | CI | | Regaine 5 % | 3 x 60 ml | PR | PR | k.A. | | Solution: Minoxidilum 50 mg/ml | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | IP | | | Mylotarg 5 mg | | PR | PR | k.A. | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Gemtuzumabum Ozogamicinum 5 mg | Pfizer AG | A | FB | | G |  |